OM

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Outset Medical (OM) Shareholders with Losses to Contact its Attorneys, Firm Investigating Possible Securities Law Violations

Retrieved on: 
Dienstag, November 7, 2023

As a result, Outset suspended 2022 and long-term financial guidance.

Key Points: 
  • As a result, Outset suspended 2022 and long-term financial guidance.
  • In late July 2022, Outset disclosed the FDA cleared the 510(k) application of Tablo for patient use in the home.
  • More recently, on Oct. 12, 2023, Outset Medical reported disappointing preliminary Q3 2023 revenues and slashed its FY 2023 revenue guidance.
  • “We’re focused on investors’ losses and investigating whether Outset may have misled investors about Tablo’s near-term prospects,” said Reed Kathrein, the Hagens Berman partner leading the investigation.

Outset Medical (OM) Investigated for Possible Securities Law Violations: Hagens Berman, National Trial Attorneys, Encourages Investors with Losses to Contact the Firm

Retrieved on: 
Dienstag, Oktober 31, 2023

As a result, Outset suspended 2022 and long-term financial guidance.

Key Points: 
  • As a result, Outset suspended 2022 and long-term financial guidance.
  • In late July 2022, Outset disclosed the FDA cleared the 510(k) application of Tablo for patient use in the home.
  • More recently, on Oct. 12, 2023, Outset Medical reported disappointing preliminary Q3 2023 revenues and slashed its FY 2023 revenue guidance.
  • “We’re focused on investors’ losses and investigating whether Outset may have misled investors about Tablo’s near-term prospects,” said Reed Kathrein, the Hagens Berman partner leading the investigation.

Hagens Berman Encourages Outset Medical (OM) Shareholders with Losses to Contact its Attorneys, Firm Investigating Possible Securities Law Violations

Retrieved on: 
Freitag, Oktober 27, 2023

SAN FRANCISCO, Oct. 27, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Outset Medical, Inc. (NASDAQ: OM) investors who suffered substantial losses to submit your losses now .

Key Points: 
  • SAN FRANCISCO, Oct. 27, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Outset Medical, Inc. (NASDAQ: OM) investors who suffered substantial losses to submit your losses now .
  • In late July 2022, Outset disclosed the FDA cleared the 510(k) application of Tablo for patient use in the home.
  • More recently, on Oct. 12, 2023, Outset Medical reported disappointing preliminary Q3 2023 revenues and slashed its FY 2023 revenue guidance.
  • “We’re focused on investors’ losses and investigating whether Outset may have misled investors about Tablo’s near-term prospects,” said Reed Kathrein, the Hagens Berman partner leading the investigation.

ADLINK Reveals All New Open Frame and True Flat Industrial Touch Monitors

Retrieved on: 
Donnerstag, November 2, 2023

SAN JOSE, Calif., Nov. 2, 2023 /PRNewswire-PRWeb/ --

Key Points: 
  • Wide range of screen sizes: the OM series offers 7"/10.1"/12.1"/15"/15.6"/17"/18.5"/19"/21.5"/23.8"/27.0"/32.0"/43.0" open frame design and the IM series provides 21.5"/23.8"/27.0" true flat monitors according to application needs.
  • Easy deployment: the slim and light frame design enables effortless integration and installation for a variety of spaces and uses.
  • ADLINK Technology Inc., a global leader in edge computing, is proud to introduce the latest industrial touch monitors – the OM & IM Series.
  • We offer comprehensive industrial-grade touch monitors and smart panel PCs with one-stop value-added customization with our experts.

Outset Medical (PM) Investigated for Possible Securities Law Violations, Hagens Berman Encourages Investors with Losses to Contact its Attorneys

Retrieved on: 
Donnerstag, Oktober 19, 2023

As a result, Outset suspended 2022 and long-term financial guidance.

Key Points: 
  • As a result, Outset suspended 2022 and long-term financial guidance.
  • In late July 2022, Outset disclosed the FDA cleared the 510(k) application of Tablo for patient use in the home.
  • More recently, on Oct. 12, 2023, Outset Medical reported disappointing preliminary Q3 2023 revenues and slashed its FY 2023 revenue guidance.
  • “We’re focused on investors’ losses and investigating whether Outset may have misled investors about Tablo’s near-term prospects,” said Reed Kathrein, the Hagens Berman partner leading the investigation.

“Outset Medical stock nosedives due to FDA warning letter headwinds” – Hagens Berman

Retrieved on: 
Samstag, Oktober 14, 2023

In late July 2022, Outset disclosed the FDA cleared the 510(k) application of Tablo for patient use in the home.

Key Points: 
  • In late July 2022, Outset disclosed the FDA cleared the 510(k) application of Tablo for patient use in the home.
  • More recently, on Oct. 12, 2023, Outset Medical reported disappointing preliminary Q3 2023 revenues and slashed its FY 2023 revenue guidance.
  • “We’re focused on investors’ losses and investigating whether Outset may have misled investors about Tablo’s near-term prospects,” said Reed Kathrein, the Hagens Berman partner leading the investigation.
  • If you invested in Outset Medical and have significant losses, or have knowledge that may assist the firm’s investigation, click here to discuss your legal rights with Hagens Berman .

New Survey Reveals the Weighty Impact of Excess Weight for Dogs - and their Owners

Retrieved on: 
Mittwoch, Oktober 11, 2023

ST. LOUIS, Oct. 11, 2023 /PRNewswire/ -- A new survey1 from Purina Pro Plan Veterinary Diets, released today – National Pet Obesity Awareness Day – found that excess physical weight in dogs carries an emotional weight for their owners, and that many owners view their dogs as thinner than they really are. Results showed that approximately 1 in 5 dog-owning households consider one or more of their dogs to be overweight. However, according to the Association for Pet Obesity Prevention (APOP)2, the number of overweight dogs in the United States has reached a record high, with 59% of evaluated dogs in the U.S. either overweight (37%) or having obesity (22%).

Key Points: 
  • "Dogs do not always gain excess weight due to a lack of care from their owners", noted APOP President Ernie Ward, DVM.
  • "If anything, an overweight dog may be a sign that the owner cares too much about their dog's happiness.
  • The new survey revealed that excess weight gain in pets can be related to the emotions owners experience around feeding and treating:
    75% of surveyed owners agreed they feel guilty when their dogs appear hungry.
  • "While owners recognize that excess weight is keeping their dogs from participating in activities they once enjoyed, they also worry their dogs will be unhappy if feeding changes are made."

Black Dragon Capital adds award-winning credit union veteran Kirk Kordeleski, former CEO of Bethpage FCU, as Industry Advisor

Retrieved on: 
Donnerstag, Oktober 5, 2023

BOCA RATON, Fla., Oct. 5, 2023 /PRNewswire/ -- Black Dragon Capital℠, a multi-phased investment firm focused on advanced technologies in high growth segments that strengthen economic stability within communities, today welcomes Kirk Kordeleski as its newest Industry Advisor.

Key Points: 
  • As CEO of Bethpage Federal Credit Union (BFCU), Mr. Kordeleski grew the organization to one of the largest credit unions in the U.S., doubling assets every five years.
  • His addition as an executive advisor of Black Dragon Capital℠ demonstrates the firms continued commitment to intense operational expertise.
  • Black Dragon Capital℠ (BDC, Black Dragon) is a multi-phased investment firm focused on advanced technologies in high growth segments that strengthen economic stability within communities.
  • I am honored to work with him and the rest of the Team at Black Dragon to bring technologies that will enhance the important role that credit unions play in communities across the country," said Kirk Kordeleski, Industry Advisor, Black Dragon Capital.

The LUMIX G9II

Retrieved on: 
Dienstag, September 12, 2023

NEWARK, N.J., Sept. 12, 2023 /PRNewswire/ -- Panasonic is proud to announce the launch of the LUMIX G9II digital mirrorless camera, equipped with a new sensor and Phase Detection Auto-Focus (PDAF) technology. The LUMIX G9II is the first camera in the Micro Four Thirds LUMIX G Series to feature PDAF technology.

Key Points: 
  • NEWARK, N.J., Sept. 12, 2023 /PRNewswire/ -- Panasonic is proud to announce the launch of the LUMIX G9II digital mirrorless camera, equipped with a new sensor and Phase Detection Auto-Focus (PDAF) technology.
  • The LUMIX G9II is the first camera in the Micro Four Thirds LUMIX G Series to feature PDAF technology.
  • The LUMIX G9II will be available at valued channel partners in early November for $1899.99 MSRP.
  • Panasonic is pleased to introduce a new battery grip equipped with an eight-direction joystick that is compatible with the LUMIX G9II and the already available LUMIX S5II and S5IIX.

Digital Camera Market size to grow by USD 3.15 billion from 2022 to 2027, Canon Inc., Elite Brands Inc., FUJIFILM Corp., and more among key companies- Technavio

Retrieved on: 
Freitag, September 8, 2023

NEW YORK, Sept. 8, 2023 /PRNewswire/ -- The digital camera market size is expected to grow by USD 3.15 billion from 2022 to 2027.

Key Points: 
  • NEW YORK, Sept. 8, 2023 /PRNewswire/ -- The digital camera market size is expected to grow by USD 3.15 billion from 2022 to 2027.
  • In addition, the growth momentum of the market will progress at a CAGR of 5.55% during the forecast period, according to Technavio.
  • Availability in various price ranges is notably driving the digital camera market.
  • Canon Inc. - The company offers digital cameras such as Canon EOS 1500D, Canon EOS 200D, and Canon EOS R10.